Recor Medical develops advanced medical technologies aimed at improving treatment options for individuals with hypertension, a leading cardiovascular risk factor globally. Their flagship product, the Paradise ultrasound renal denervation (uRDN) system, offers a non-drug, minimally invasive solution to help lower blood pressure for millions of patients. The company emphasizes a collaborative and innovative culture, seeking diverse perspectives to drive meaningful improvements in patient care. Recor Medical's commitment to quality and continuous improvement is reflected in their focus on rigorous regulatory compliance and safety measures. They value teamwork, aiming to create an environment where employees are encouraged to challenge the status quo and contribute to the advancement of healthcare solutions that positively impact the lives of patients around the world.